168 related articles for article (PubMed ID: 37523119)
1. Cancer Stem Cells Persist Despite Cellular Damage, Emergence of the Refractory Cell Population.
Nagae A; Miyoshi N; Fujino S; Horie M; Yachida S; Sasaki M; Sekido Y; Hata T; Hamabe A; Ogino T; Takahashi H; Uemura M; Yamamoto H; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Oct; 30(11):6913-6924. PubMed ID: 37523119
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
Okuyama H; Nogami W; Sato Y; Yoshida H; Tona Y; Tanaka Y
Anticancer Res; 2020 Jan; 40(1):169-176. PubMed ID: 31892565
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression.
Miyoshi S; Tsugawa H; Matsuzaki J; Hirata K; Mori H; Saya H; Kanai T; Suzuki H
Anticancer Res; 2018 Nov; 38(11):6163-6170. PubMed ID: 30396933
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
7. Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors.
Shigeishi H; Biddle A; Gammon L; Rodini CO; Yamasaki M; Seino S; Sugiyama M; Takechi M; Mackenzie IC
J Oral Pathol Med; 2015 Mar; 44(3):201-7. PubMed ID: 25169655
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling Warburg effect and stemness in CD133
Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
[TBL] [Abstract][Full Text] [Related]
9. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs.
Rao GH; Liu HM; Li BW; Hao JJ; Yang YL; Wang MR; Wang XH; Wang J; Jin HJ; Du L; Chen Q
Acta Pharmacol Sin; 2013 Jun; 34(6):793-804. PubMed ID: 23736004
[TBL] [Abstract][Full Text] [Related]
11. CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance.
Yoon C; Park DJ; Schmidt B; Thomas NJ; Lee HJ; Kim TS; Janjigian YY; Cohen DJ; Yoon SS
Clin Cancer Res; 2014 Aug; 20(15):3974-88. PubMed ID: 24947926
[TBL] [Abstract][Full Text] [Related]
12. Autophagy regulates chemoresistance of gastric cancer stem cells via the Notch signaling pathway.
Li LQ; Pan D; Zhang SW; -Y-Xie D; Zheng XL; Chen H
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3402-3407. PubMed ID: 29917191
[TBL] [Abstract][Full Text] [Related]
13. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
[TBL] [Abstract][Full Text] [Related]
14. CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure.
Tsunekuni K; Konno M; Haraguchi N; Koseki J; Asai A; Matsuoka K; Kobunai T; Takechi T; Doki Y; Mori M; Ishii H
Sci Rep; 2019 Oct; 9(1):14861. PubMed ID: 31619711
[TBL] [Abstract][Full Text] [Related]
15. RHAMM marks proliferative subpopulation of human colorectal cancer stem cells.
Nakano M; Taguchi R; Kikushige Y; Isobe T; Miyawaki K; Mizuno S; Tsuruta N; Hanamura F; Yamaguchi K; Yamauchi T; Ariyama H; Kusaba H; Nakamura M; Maeda T; Kuo CJ; Baba E; Akashi K
Cancer Sci; 2023 Jul; 114(7):2895-2906. PubMed ID: 36945114
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
[TBL] [Abstract][Full Text] [Related]
17. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.
Shi C; Tian R; Wang M; Wang X; Jiang J; Zhang Z; Li X; He Z; Gong W; Qin R
Cancer Biol Ther; 2010 Dec; 10(11):1182-90. PubMed ID: 20948317
[TBL] [Abstract][Full Text] [Related]
18. CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field.
Su Z; Liu D; Chen L; Zhang J; Ru L; Chen Z; Gao Z; Wang X
Int J Nanomedicine; 2019; 14():7549-7560. PubMed ID: 31571863
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
20. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.
Hong SP; Wen J; Bang S; Park S; Song SY
Int J Cancer; 2009 Nov; 125(10):2323-31. PubMed ID: 19598259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
